ACIU · NASDAQ · Biotechnology

AC Immune

Develops protein-misfolding therapies and diagnostics for neurodegenerative diseases.

$2.65
After-hours close−0.02 (−0.56%)
At close$2.67(−1.66%)
DateEstimateReportedSurprise
Nov 2026−$0.22
Aug 2026−$0.10$0.03+128.7%
Apr 2026−$0.20−$0.19+5.0%
Mar 2026−$0.19−$0.18+5.3%
Nov 2025−$0.22−$0.20+9.1%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 2025
Apr 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
Apr 2023
Mar 2023
Oct 2022
Jul 2022
Apr 2022
Mar 2022
Nov 2021
Aug 2021
Apr 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Mar 2020
Nov 2019
Aug 2019
May 2019
Mar 2019
Nov 2018
Aug 2018
May 2018
Mar 2018
Nov 2017
Aug 2017
May 2017
Mar 2017
Nov 2016
Sep 2016
Jun 2016
Dec 2015
Sep 2015
Jun 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 3, 2026−$0.22$248.3K
Aug 5, 2026−$0.10$0.03+128.7%$9.6M$9.8M+2.6%
Apr 30, 2026−$0.20−$0.19+5.0%$329.4K$1.4M+325.0%
Mar 13, 2026−$0.19−$0.18+5.3%$1.4M$428.9K−70.3%
Nov 4, 2025−$0.22−$0.20+9.1%$1.1M$1.2M+3.2%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 5, 2025
Apr 30, 2025
Mar 13, 2025
Nov 5, 2024
Aug 6, 2024
May 13, 2024
Mar 14, 2024
Nov 3, 2023
Aug 4, 2023
Apr 28, 2023
Mar 16, 2023
Oct 28, 2022
Jul 28, 2022
Apr 28, 2022
Mar 22, 2022
Nov 8, 2021
Aug 4, 2021
Apr 28, 2021
Mar 23, 2021
Nov 13, 2020
Aug 5, 2020
May 4, 2020
Mar 30, 2020
Nov 13, 2019
Aug 14, 2019
May 15, 2019
Mar 21, 2019
Nov 13, 2018
Aug 8, 2018
May 2, 2018
Mar 20, 2018
Nov 13, 2017
Aug 9, 2017
May 11, 2017
Mar 17, 2017
Nov 11, 2016
Sep 23, 2016
Jun 30, 2016
Dec 31, 2015
Sep 30, 2015
Jun 30, 2015